CAS RN: 1072413-83-2
UiO-66-BPDC/UiO-67, BPDC:Zr=0.9-1.0,Zirconium biphenyldicarboxylate MOF
Product Availability
Choose a grade to view its available package options.
5 package records1 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260106 |
100mg |
Out of stock |
| Inquiry |
| Batchno.20250521 |
1g |
Out of stock |
| Inquiry |
| Batchno.20250325 |
250mg |
Out of stock |
| Inquiry |
| Batchno.20250530 |
5g |
Out of stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260317 |
100mg / 250mg / 1g |
Confirm by inquiry |
Shanghai | Inquiry |
-
Product code:
starshine_CAS1072413-83-2
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1072413-83-2 / hexakis(4-(4-carboxylatophenyl)benzoate);tetrakis(oxygen(2-));hexakis(zirconium(4+));tetrahydroxide
UiO 67 | CS-0111607
Standard CAS: 1072413-83-2
Multi CAS: Yes
Basic Information
CAS
1072413-83-2
Multi CAS
Yes
Molecular Formula
C84H52O32Zr6
Molecular Weight
2120.600000
Exact Mass
2117.674312
SMILES
C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)[O-])C(=O)[O-].[OH-].[OH-].[OH-].[OH-].[O-2].[O-2].[O-2].[O-2].[Zr+4].[Zr+4].[Zr+4].[Zr+4].[Zr+4].[Zr+4]
InChI
InChI=1S/6C14H10O4.4H2O.4O.6Zr/c6*15-13(16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)14(17)18;;;;;;;;;;;;;;/h6*1-8H,(H,15,16)(H,17,18);4*1H2;;;;;;;;;;/q;;;;;;;;;;4*-2;6*+4/p-16
InChIKey
AYROWDHTBQISAN-UHFFFAOYSA-A
Synonyms
UiO 67
CS-0111607
Computed Properties
Structural Parameters
Heavy atom count
122
Aromatic heavy atom count
72
Rotatable bonds
18
H-bond acceptors
28
H-bond donors
4
Molar refractivity
373.72
TPSA
715.56
LogP / Solubility
WLOGP
-0.71
MLOGP
-0.4
XLogP3
-0.71
Consensus LogP
-0.61
Log S (ESOL)
-11.79
Class (ESOL)
Insoluble
Log S (Ali)
-16.43
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-15.01
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-16.16
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
8.5